Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Etodolac 600mg modified-release tablets
1001010E0AAADAD
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | 19,255 |
|
Etodolac 300mg capsules
1001010E0AAACAC
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | 1 |
|
Etodolac 200mg capsules
1001010E0AAAAAA
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.